Form 4: Edwards Lifesciences Executive Daniel J. Lippis Reports Stock Disposal
SEC Form 4 Filing
Daniel J. Lippis, CVP of JAPAC at Edwards Lifesciences, reported the disposal of 377 shares of common stock to cover tax obligations.
Summary
- On May 11, 2024, Daniel J. Lippis, CVP of JAPAC at Edwards Lifesciences Corp, disposed of 377 shares of common stock.
- The transaction was executed at a price of $86.72 per share.
- Following the transaction, Lippis directly owns 23,512.7443 shares of Edwards Lifesciences common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction filing, and the sentiment is neutral as it reflects standard executive compensation practices.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates a stock disposal by an executive, which is a common occurrence for tax purposes or portfolio diversification.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders, as it is a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 05/11/2024 | Date of stock disposal transaction |
| 05/13/2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.